Zeer CellCarta / intent / cellcarta

CellCarta

501-1000 employees·Montreal, Québec, Canada·cellcarta.com

Observed, not inferred · updated weekly

Buying intent

51 tracked signals | Top 15 topics are below | Sales and Operations are carrying most of it.

39signals · 30 days
27topics tracked
37.04%attributed to a team

Attention by team

LinkedIn activity, by team

Where CellCarta's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.

Pharmaceutical
Gene Therapy
Precision Medicine
Artificial Intelligence
Supply Chain
Flow Cytometry
Sales
Low14% of team Sales to Pharmaceutical: Low, 14% of this team's signals
Low14% of team Sales to Gene Therapy: Low, 14% of this team's signals
Medium29% of team Sales to Precision Medicine: Medium, 29% of this team's signals
Low14% of team Sales to Artificial Intelligence: Low, 14% of this team's signals
Low14% of team Sales to Supply Chain: Low, 14% of this team's signals
Low14% of team Sales to Flow Cytometry: Low, 14% of this team's signals
Operations
Operations to Pharmaceutical: no signal
Operations to Gene Therapy: no signal
Low33% of team Operations to Precision Medicine: Low, 33% of this team's signals
Low33% of team Operations to Artificial Intelligence: Low, 33% of this team's signals
Operations to Supply Chain: no signal
Low33% of team Operations to Flow Cytometry: Low, 33% of this team's signals
Others
High29% of team Others to Pharmaceutical: High, 29% of this team's signals
High24% of team Others to Gene Therapy: High, 24% of this team's signals
Medium12% of team Others to Precision Medicine: Medium, 12% of this team's signals
Medium12% of team Others to Artificial Intelligence: Medium, 12% of this team's signals
Medium18% of team Others to Supply Chain: Medium, 18% of this team's signals
Low6% of team Others to Flow Cytometry: Low, 6% of this team's signals
LowMediumHigh·  banded against the busiest pairing on this page

Topics being researched

30-day window

Every tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.

Pharmaceutical
LinkedIn
High volume
97%
last
17d ago
Gene Therapy
LinkedIn
High volume
98%
last
17d ago
Precision Medicine
LinkedIn
High volume
98%
last
13d ago
Artificial Intelligence
LinkedIn
High volume
96%
last
18d ago
Supply Chain
LinkedIn
High volume
92%
last
23d ago
Flow Cytometry
LinkedIn
Medium volume
92%
last
25d ago
CAR-T Cell Therapy
LinkedIn
Medium volume
92%
last
25d ago
Cancer Research
LinkedIn
Medium volume
97%
last
25d ago
Drug Development
LinkedIn
Medium volume
97%
last
25d ago
Cell Therapy Manufacturing
LinkedIn
Low volume
98%
last
23d ago
Oncology
LinkedIn
Low volume
94%
last
25d ago
Power BI
LinkedIn
Low volume
98%
last
27d ago
Cell Therapy
LinkedIn
Low volume
96%
last
25d ago
Human Resources -> Payroll and Compensation
LinkedIn
Low volume
98%
last
18d ago
Product Launch
LinkedIn
Low volume
96%
last
25d ago

Need intent for a specific topic or industry?

We track the full taxonomy across every account in the graph — including themes not shown on this page.

Talk to us

Who's active at CellCarta

verified title on file

Titles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.

Others10 active
VPresearching Pharmaceutical
in
Executiveresearching Drug Development
in
Directorresearching Artificial Intelligence
in
researching Pharmaceutical
in
Leadershipresearching Power BI
in
Directorresearching Precision Medicine
in
Leadershipresearching Quality Assurance
in
Leadershipresearching Precision Medicine
in
Directorresearching Flow Cytometry
in
Sales5 active
business development associate director
researching Cancer Research
in
director, business development
researching Supply Chain
in
senior director, scientific business development
researching T cells
in
Business Development Director
Directorresearching Cell Processing System
in
Senior Director Business Development
researching Precision Medicine
in
+ 5 more in Sales
Operations2 active
Vice President and Global Head of Science, Innovation and Development
VPresearching Risk threshold
in
Vice President Operations
VPresearching Precision Medicine
in
+ 2 more in Operations
Support1 active
Sale Support Specialist
researching Human Resources -> Payroll and Compensation
in
+ 1 more in Support

See everyone, not just the first 10

18 people across every department at CellCarta, plus a LinkedIn profile link for each.

Primary products / business lines

LinkedIn company profile

CellCarta is a leading global CRO laboratory to the biopharmaceutical and biotechnology industries. We partner with translational medicine, biomarker, and clinical development teams to generate reliable, regulatory-ready data that supports complex clinical development. With fully owned and harmonized laboratory operations across North America, Europe, Australia, and China, CellCarta delivers inte

New capability sought

Employee posts (LinkedIn)

Supply Chain; CAR-T Cell Therapy; Cancer Research; Drug Development

Top accounts researching CellCarta

names withheld on the public page

These are companies whose own people brought up CellCarta unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.

6,459 companies · 25,813 people are researching Pharmaceutical

CellCarta's own team shows 6 signals on this topic. No one outside CellCarta has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.

  • Gene Therapy675 cos · 1,971 people
  • Precision Medicine1,307 cos · 4,297 people
Sign up to see which companies →

Buyer profile

company size · seniority

Company size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.

Unlock the buyer profile

Company-size breakdown and buyer seniority mix for accounts researching CellCarta.

Company size breakdown
Buyer seniority mix

Sign up to learn more

Create an account to explore buyer insights as they become available.

Sign up to learn more →

Buying committee functions

Employee job titles (LinkedIn)

Sales — 5 people; IT — 2 people; Operations — 1 person; Leadership — 1 person

What's been said

public posts mentioning CellCarta

Up to 9 public excerpts naming CellCarta from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.

LinkedIn

As I celebrate and reflect on the past four years at CellCarta - what a privilege it is to work for this company, in this industry, with the most amazing sponsors and with this fantastic team! 🧪🩷 As another visit to the Boston area wraps up today - the smile on my face is hard to remove and it is not just because of a visit to Fenway ⚾️ Next stop ... #ASCO #cellcarta #workanniversary #clinicaltrials #biomarkers

May 2026
LinkedIn

Early-stage programs move fast. Your CRO should move even faster. We understand your programs can't afford to wait for results or get tangled in the regulatory overhead built for late-stage programs. Our California laboratory (part of CellCarta 's global network) is uniquely positioned to support your early-stage programs. From assay development to pathologist-validated biomarker readouts, we deliver rapid turnaround times without sacrificing the scientific rigor you require to advance your programs. And when your program scales, so do we, with our global network of fully owned labs. What does your early-stage program need most right now: speed, scientific partnership, or specimen access? Learn more about how we can offer all three: https://bit.ly/4ddxsO8 #Biotech #AssayDevelopment #Biomarkers #EarlyStage #ClinicalDevelopment

May 2026

About this data. CellCarta (cellcarta.com). Department attribution is 37.04%; remaining activity is grouped under Others. Updated 2026-10-03T14:00:03.490Z.

Not yet computedPer-team narrative summaries